Cognitive aids help the stressed practitioner in an emergency setting carry out complex tasks. Ideally, they ensure the completion of key steps and prevent unnecessary ones. Malignant hyperthermia is an emergency event that lends itself to the use of a cognitive aid. Experts associated with the Malignant Hyperthermia Association (MHAUS) first developed a cognitive aid in the form of a “poster” in the mid-1980s
The EMHG first published its protocol for an in vitro contracture test (IVCT) in 19841 and this has ...
Malignant hyperthermia (MH) is a relatively rare, but potentially lethal genetic disorder. That dise...
Background: The autosomal dominant inherited trait of malignant hyperthermia (MH) may result in a fa...
Malignant hyperthermia (MH) is a potentially fatal, inherited disorder of muscle hypermetabolism tha...
Rethinking Malignant Hyperthermia Protocols In person poster Undergraduate Student: Currie, Kelsey R...
Background Malignant hyperthermia (MH) is a rare, hereditary disease with a hypermetabolic response ...
Survival from a malignant hyperthermia (MH) crisis is highly dependent on early recognition and prom...
Malignant Hyperthermia is a rare but fatal disorder usually triggered using succinylcholine, a depol...
Purpose: Malignant hyperthermia is a rare crisis associated with anesthesia that boasts an 80%fatali...
Purpose: Malignant hyperthermia (MH) is a critical and potentially life-threatening emergency associ...
Purpose: The focus of the quality improvement (QI) project was to improve provider preparedness for ...
Background: A cognitive aid is defined by the Stanford Anesthesia Cognitive Aid Group as a visual in...
Malignant Hyperthermia Simulation Rachael Tse, BSN, RN and Michael Quidort, BSN, RN Faculty Sponsor:...
Background Malignant hyperthermia (MH) is a potentially fatal reaction to a volatile anesthetic or s...
Abstract Malignant Hyperthermia (MH) is a rare inherited disorder in which exposure to triggering ag...
The EMHG first published its protocol for an in vitro contracture test (IVCT) in 19841 and this has ...
Malignant hyperthermia (MH) is a relatively rare, but potentially lethal genetic disorder. That dise...
Background: The autosomal dominant inherited trait of malignant hyperthermia (MH) may result in a fa...
Malignant hyperthermia (MH) is a potentially fatal, inherited disorder of muscle hypermetabolism tha...
Rethinking Malignant Hyperthermia Protocols In person poster Undergraduate Student: Currie, Kelsey R...
Background Malignant hyperthermia (MH) is a rare, hereditary disease with a hypermetabolic response ...
Survival from a malignant hyperthermia (MH) crisis is highly dependent on early recognition and prom...
Malignant Hyperthermia is a rare but fatal disorder usually triggered using succinylcholine, a depol...
Purpose: Malignant hyperthermia is a rare crisis associated with anesthesia that boasts an 80%fatali...
Purpose: Malignant hyperthermia (MH) is a critical and potentially life-threatening emergency associ...
Purpose: The focus of the quality improvement (QI) project was to improve provider preparedness for ...
Background: A cognitive aid is defined by the Stanford Anesthesia Cognitive Aid Group as a visual in...
Malignant Hyperthermia Simulation Rachael Tse, BSN, RN and Michael Quidort, BSN, RN Faculty Sponsor:...
Background Malignant hyperthermia (MH) is a potentially fatal reaction to a volatile anesthetic or s...
Abstract Malignant Hyperthermia (MH) is a rare inherited disorder in which exposure to triggering ag...
The EMHG first published its protocol for an in vitro contracture test (IVCT) in 19841 and this has ...
Malignant hyperthermia (MH) is a relatively rare, but potentially lethal genetic disorder. That dise...
Background: The autosomal dominant inherited trait of malignant hyperthermia (MH) may result in a fa...